Structural, functional and endothelial peculiarities of diabetic nephropathy in patients with arterial hypertension
Abstract
The aim of our one-stage observational study was the detail analysis of structural, functional, endothelial peculiarities of diabetic nephropathy in patients with coexistent arterial hypertension.
Methods. Our study involved 96people with arterial hypertension and type 2 diabetes mellitus (I group), 25 patients with arterial hypertension (II group), 15 practically healthy persons (III group) treated and obtained in Sumy City Clinical Hospital №1. Cardiovascular complications were determined in all patients from I and II groups. The average age of the patients was 62.31 ± 0.2 years. The level of glycosylated hemoglobin (HbAlc) was determined by the biochemical method, albuminuria by immunoassay. The level of endothelin-1 (ET-1) in serum was studied using ELISA.
Results. It was found that the level of ET-1 was significantly higher in patients with diabetes compared with only hypertensive patients. In the patients with urine albumin excretion rate category A2 the level of endothelin-1 was significantly higher compared with the category A1 patients and less compared with category A3 patients (11.42 ± 49 vs 25 ± 0.57pg/ml, p = 0.0329 and 11.42 ± 0.49 vs 2.25 ± 1.04pg/ml, p <0.0001, respectively. So, the level of ET-1 increased in proportion to albuminuria. In patients with the albuminuria category A2, the endothelin-1 level was higher than in subjects with the A1 category and lower than in patients with the A3 category. In addition, we identified a moderate direct correlation between the blood level of ET-1 in the patients with diabetes and blood glucose level (r = 0.29;p = 0.004).
Conclusion. Finally, it is the confirmation of greater endothelial function disorders for arterial hypertension and type 2 diabetes mellitus. In conclusion, endothelial dysfunction promotes diabetic nephropathy progression.
Downloads
References
ESH/ESC 2013 Guidelines for the manage- ment of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013;34(28):2159-219. doi: 10.1093/eur-heartj/eht151
Bilovol OM, Shalimova AS, Kochueva MM. Comorbidity of essential hypertension and type 2 diabetes mellitus is an actual problem of mor- den medicine. Ukrainian therapeutical journal. 2014;1:11-7. [In Ukrainian].
Оspanova TS., Zaozerskaya NV. Clinical and Pathogenetic Features of Respiratory Disorders in Patients with Diabetic Nephropathy and Obesity. Visnyk problem biolohii i medytsyny. 2014;1(106):157-61. [In Ukrainian].
Nakaz Ministerstva okhorony zdorovia vid 24.05.2012 № 384. Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh do- kumentiv zi standartyzatsii medychnoi dopomo- hy pry arterialnii hipertenzii. Onovlena ta adap- tovana clinichna nastanova, zasnovana na doka- zakh. [Internet]. [In Ukrainian]. Available from: https://www.apteka.ua/article/151151
Unifikovanyi klinichnyi protokol pervyn- noi ta vtorynnoi (spetsializovanoi) medychnoi dopomogy «Tsukrovyi diabet 2 typu»: Nakaz Ministerstva okhorony zdorovia vid 21.12.2012 № 1118. – 118 p. [Internet]. [In Ukrainian]. Dostupno: http://mtd.dec.gov.ua/images/dodat- ki/2012_1118/2012_1118_nakaz.pdf
American Diabetes Association. Standards of Medical Care in Diabetes – 2017. Diabetes Care. [Internet]. 2017;40(1):1-142. Available from: http://care.diabetesjournals.org/content/dia- care/suppl/2016/12/15/40.Supplement_1.DC1/ DC_40_S1_final.pdf
National Kidney Foundation. KDIGO 2012 clini- cal practice guideline for the evaluation and man- agement of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1-150.
Sun YM, Su Y, Li J, Wang LF. Recent advances in understanding the biochemical and molecu- lar mechanism of diabetic nephropathy. Biochem Biophys Res Commun. 2013Apr19;433(4):359-61. doi: 10.1016/j.bbrc.2013.02.120.
Pertseva NO. Relationship of hyperglycemia with endothelial function, renal function, lipidemic profi le, and morphological changes of blood cells in patients with insuffi cient compensation of type 2 diabetes mellitus with hypertension. Zaporozhye med journ. 2014; 6 (87): 11-7. [In Ukrainian].
Prystupiuk LO. Determination of albuminuria as a component of screening for type 2 diabetes mel- litus. Int J Endocrinol. 2015;2(66):34-6.
Pernow J, Shemyakin A, Böhm F. New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sci J. 2012 Oct 15;91(13-14):507-16. doi: 10.1016/j.lfs.2012.03.029.
Kochueva MN, Havryliuk BA. Neuroendocrine mechanisms of development of nephropathy of pa- tients with an essential hypertension and obesity. The East Eur J Intern And Fam Med. 2014;1:43- 50 [In Russian].
